21 reports

  • PERFORMANCE/INITIATIVES OF EXISTING AND UPCOMING VENDORS IN GLOBAL PROSTATE CANCER DRUGS MARKET
  • MARKET PENETRATION OF VARIOUS PROSTATE CANCER DRUG MANUFACTURERS WORLDWIDE 2015

About Prostate Cancer Drugs Prostate cancer is the cancer of prostate gland. According to CDC, it is one of the leading cause of cancer death in men across the races in the US. According to the Urology Care Foundation, globally, one in seven men will be diagnosed with the disease. About one in 35 men die due to prostate cancer. Growth in...

  • Cancer
  • Prostate Cancer
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Sanofi S.A.
  • Eli Lilly
  • Vendor landscape

PART ##: Disease overview TYPES OF GASTRIC CANCER Gastric cancer is one of the common types of cancer.

  • Cancer
  • Gastric Cancer
  • Therapy
  • Eli Lilly & Co.
  • Sanofi S.A.
  • Global HER-2 Positive Breast Cancer Market
  • 08.3 HER-2 POSITIVE BREAST CANCER MARKET IN US

About HER-2 Positive Breast Cancer Breast cancer is characterized by uncontrolled growth of cancerous cells in the breast. It occurs in both males and females, however, the incidence of breast cancer in males is rare. Histologically, breast cancer can be classified into ductal carcinoma, lobular carcinoma, nipple cancer, and other undifferentiated...

  • Breast Cancer
  • Cancer
  • Therapy
  • Celgene Corporation
  • Sanofi S.A.
  • Global Colorectal Cancer Drugs Market
  • 17. Market Trends

About Colorectal Cancer Colorectal cancer refers to malignancies that originate in the rectum or the colon. It is also known as bowel cancer. Formation of adenocarcinomas is the most common feature of colorectal cancer. The cancer starts as a polyp in the inner wall of the colon or rectum. These polyps can be benign or malignant. Colorectal...

  • Cancer
  • Colorectal Cancer
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • Sanofi S.A.

Colorectal cancer

4546 5000 3864
  • Forecast: Colorectal Cancer
  • Marketed Drugs: Colorectal Cancer

Pipeline candidates for the colorectal cancer market will pursue novel mechanisms of action to distinguish themselves in an increasingly crowded market. This report addresses the following questions: - How are new therapies differentiating themselves in the increasingly crowded and price-sensitive CRC market? - How...

  • Cancer
  • Chemotherapy
  • Colorectal Cancer
  • Therapy
  • Sanofi S.A.
  • Zarour HM, et al. (2003). Categories of tumor antigens. Cancer Medicine; 6th Edition
  • 8.1 REFERENCES

Global Cancer Immunotherapies Market to 2024 - Increased Uptake of Immune Checkpoint Inhibitors Driving Growth, Supported by a Large, Robust Pipeline Summary Cancer immunotherapy, which can predominantly be classed as a form of targeted therapy, drives an immune response against cancer cells. This...

  • Cancer
  • Cancer Immunotherapy
  • Lung Cancer
  • Therapy
  • Sanofi S.A.

Prostate cancer

4546 5000 3864
  • Forecast: Prostate Cancer
  • LEADING TREATMENTS FOR PROSTATE CANCER

The value of the prostate cancer market will more than double during 2015–24, reaching $13.5bn in 2024 at a compound annual growth rate (CAGR) of 8.6%. This report addresses the following questions: - Which products will drive the growth of the prostate cancer market during 2015–24? - Which geographic markets will experience...

  • Cancer
  • Prostate Cancer
  • Therapy
  • Market Size
  • Sanofi S.A.
  • Global Small Cell Lung Cancer Therapeutics Market
  • 03.1 MARKET OVERVIEW

About Small Cell Lung Cancer Cancer occurs when, after cell transformation, normal cells grow and multiply without control. Lung cancer is a common cause of mortality and morbidity in developed and developing countries. Smoking is considered to be the major cause of small cell lung cancer, though it also occurs in non-smokers. Lung cancer...

  • Cancer
  • Lung Cancer
  • Therapy
  • Bristol-Myers Squibb Company
  • Sanofi S.A.
  • Executive Summary

ABOUT ## IN ## CASES OF THIS CANCER ARE HER## POSITIVE.

  • Cancer
  • AbbVie Inc.
  • F. Hoffmann-La Roche Ltd.
  • Pfizer Inc.
  • Sanofi S.A.
  • Global Monoclonal Antibody Sterile Injectables Market
  • Scope of the Report - Sterile Injectables Market

IBI## Human mAb PD-## Phase ## Squamous cell non-small cell cancer BeiGene BGB-A## Humanized mAb PD-## Phase ## Non-small cell Cancer AbbVie Rovalpituzumab Tesirine Humanized IgG## ADC DLL## Phase ## Small cell lung cancer ImmunoGen BCD-## Human mAb PD-

  • Cancer
  • Endocrine Disease
  • Baxter International Inc.
  • Gilead Sciences, Inc.
  • Sanofi S.A.
  • CRPC treatment market in EMEA
  • Competitive landscape

About one in ## men will die due to prostate cancer.

  • Cancer
  • World
  • Forecast
  • Market Size
  • Sanofi S.A.

Other Companies ##.

  • Cancer
  • Infectious Disease
  • Vaccine
  • Demand
  • Sanofi S.A.
  • Scope of the report
  • Market landscape

Biologics are one of the treatment choices for colorectal cancer.

  • Cancer
  • Colorectal Cancer
  • Therapy
  • Amgen Inc.
  • Sanofi S.A.
  • 07.1 MARKET OVERVIEW
  • 18.1 COMPETITIVE SCENARIO

About HER-2 Positive Breast Cancer Breast cancer is characterized by uncontrolled growth of cancerous cells in the breast. It occurs in both males and females, however, the incidence of breast cancer in males is rare. Histologically, breast cancer can be classified into ductal carcinoma, lobular carcinoma, nipple cancer, and other undifferentiated...

  • Breast Cancer
  • Cancer
  • Therapy
  • Market Segment
  • Sanofi S.A.
  • CHAPTER III CERVICAL CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS
  • Cervical Cancer Treatment Drugs Production and Demand

The Cervical Cancer Chapter V CERVICAL CANCER TREATMENT DRUGS MARKET OUTLOOK Treatment Drugs industry is one of the pillar industries in China.

  • Cancer
  • Cervical Cancer
  • Pharmaceutical
  • Hubei HONCH Pharmaceutical Co., Ltd.
  • Sanofi S.A.

THE PAP TEST IS ONE OF THE MOST RELIABLE AND EFFECTIVE CANCER SCREENING METHODS AVAILABLE, AND WOMEN SHOULD HAVE YEARLY EXAMS BY AN OB-GYN.

  • Cancer
  • Infectious Disease
  • Vaccine
  • World
  • Sanofi S.A.
  • 201 FOR PROSTATE CANCER
  • CO-DEVELOPMENT AGREEMENT FOR CANCER THERAPEUTICS

The Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018 report provides comprehensive understanding and unprecedented access to the co-development deals and agreements entered into by the worlds leading life science companies. This report provides details of the latest...

  • Cancer
  • Pharmaceutical
  • AbbVie Inc.
  • Amgen Inc.
  • Sanofi S.A.
  • CHAPTER III CERVICAL CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

It can control the spread of cancer cells, and extend the life time of patients who are ill with cervical cancer.

  • Cancer
  • Cervical Cancer
  • Pharmaceutical
  • Eli Lilly & Co.
  • Sanofi S.A.

Hoffmann-La Roche Ltd. ## ## ## ## ## ## ## ## Amgen Inc. ## ## ## ## ## ## ## ## AbbVie Inc. ## ## ## ## ## ## ## ## Source: GlobalData' s Pharma eTrack Clinical Trials Database (*)Trials are taken for a time period of 1995 - 2015 2015 trials are taken as of Augu

  • Cancer
  • Clinical Trial
  • Hospital
  • Lymphoma
  • Sanofi S.A.
  • 7. MARKET FORECAST AND OPPORTUNITY ANALYSIS

TARGET PATIENT POPULATION ## Metastatic Pancreatic Cancer (with high serum levels of free IGF-##) In 2014, there were an estimated ##, ## people living with pancreatic cancer in the US.

  • Cancer
  • Therapy
  • Ablynx NV
  • Amgen Inc.
  • Sanofi S.A.
  • 7. Key Product Analysis
  • 6. Competitive Landscape

It is currently in Phase ## clinical development.

  • Cancer
  • United States
  • World
  • Forecast
  • Sanofi S.A.